FDA Inspection 1099094 — Takeda Pharamaceutical Company Limited
The FDA completed an inspection of Takeda Pharamaceutical Company Limited on July 17, 2019 in Longmont, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 17, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Longmont, CO (United States)